HEADER TRANSFERASE 30-JUN-04 1TVO TITLE THE STRUCTURE OF ERK2 IN COMPLEX WITH A SMALL MOLECULE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ERK2, EXTRACELLULAR SIGNAL-REGULATED KINASE 2, ERK-2, COMPND 5 MITOGEN-ACTIVATED PROTEIN KINASE 2, MAP KINASE 2, MAPK 2, P42-MAPK, COMPND 6 ERT1; COMPND 7 EC: 2.7.1.37; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_CELL: DH5ALFA; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX-6P-1 KEYWDS KINASE, PROTEIN-INHIBITOR COMPLEX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR T.KINOSHITA REVDAT 4 13-MAR-24 1TVO 1 REMARK SEQADV REVDAT 3 11-OCT-17 1TVO 1 REMARK REVDAT 2 24-FEB-09 1TVO 1 VERSN REVDAT 1 13-SEP-05 1TVO 0 JRNL AUTH M.OHORI,T.KINOSHITA,M.OKUBO,K.SATO,A.YAMAZAKI,H.ARAKAWA, JRNL AUTH 2 S.NISHIMURA,N.INAMURA,H.NAKAJIMA,M.NEYA,H.MIYAKE,T.FUJII JRNL TITL IDENTIFICATION OF A SELECTIVE ERK INHIBITOR AND STRUCTURAL JRNL TITL 2 DETERMINATION OF THE INHIBITOR-ERK2 COMPLEX JRNL REF BIOCHEM.BIOPHYS.RES.COMMUN. V. 336 357 2005 JRNL REFN ISSN 0006-291X JRNL PMID 16139248 JRNL DOI 10.1016/J.BBRC.2005.08.082 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2002 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.03 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 996594.620 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.9 REMARK 3 NUMBER OF REFLECTIONS : 12794 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.265 REMARK 3 R VALUE (WORKING SET) : 0.263 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 656 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.011 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.66 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1969 REMARK 3 BIN R VALUE (WORKING SET) : 0.2710 REMARK 3 BIN FREE R VALUE : 0.2800 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 119 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.023 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2847 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 25 REMARK 3 SOLVENT ATOMS : 148 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 36.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.32000 REMARK 3 B22 (A**2) : 6.15000 REMARK 3 B33 (A**2) : -4.82000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.49000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM SIGMAA (A) : 0.16 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.16 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.600 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.910 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : GROUP REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : BABINET REMARK 3 KSOL : NULL REMARK 3 BSOL : 280.0 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : FR180204.XPARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1TVO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 05-JUL-04. REMARK 100 THE DEPOSITION ID IS D_1000022948. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-JUN-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL32B2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR (MSC/RIGAKU) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12794 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 44.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG5000, AMMONIUM SULPHATE, REMARK 280 DITHIOTHREITOL, PH 6.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.99500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 ALA A 7 REMARK 465 TYR A 358 REMARK 465 ARG A 359 REMARK 465 SER A 360 REMARK 465 GLY A 361 REMARK 465 ASP A 362 REMARK 465 LEU A 363 REMARK 465 GLY A 364 REMARK 465 SER A 365 REMARK 465 ASP A 366 REMARK 465 GLU A 367 REMARK 465 LEU A 368 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 9 -156.91 -165.76 REMARK 500 GLU A 12 131.61 76.45 REMARK 500 VAL A 14 -103.54 -91.03 REMARK 500 THR A 26 -158.27 -143.14 REMARK 500 ASN A 27 69.61 31.60 REMARK 500 GLU A 33 115.43 178.71 REMARK 500 ALA A 35 -66.13 78.25 REMARK 500 VAL A 46 -90.86 71.77 REMARK 500 LYS A 48 90.46 -58.27 REMARK 500 THR A 118 -37.16 -131.00 REMARK 500 ASP A 149 37.14 -151.24 REMARK 500 CYS A 166 -21.92 -143.04 REMARK 500 ALA A 174 -100.72 -31.58 REMARK 500 ASP A 175 69.69 77.16 REMARK 500 LEU A 184 33.03 70.33 REMARK 500 GLU A 186 150.36 -48.78 REMARK 500 LEU A 200 -61.26 -97.16 REMARK 500 ASN A 201 34.60 -158.68 REMARK 500 SER A 223 14.42 -144.26 REMARK 500 ARG A 225 140.44 -179.14 REMARK 500 CYS A 254 -161.29 63.27 REMARK 500 ILE A 255 74.29 56.81 REMARK 500 LEU A 294 47.04 -106.08 REMARK 500 ASP A 318 92.56 -171.98 REMARK 500 GLU A 334 144.22 63.95 REMARK 500 LEU A 335 -86.77 -45.80 REMARK 500 ASP A 336 -75.20 -75.33 REMARK 500 ASP A 337 101.11 -32.43 REMARK 500 LEU A 338 105.68 161.13 REMARK 500 PRO A 356 104.30 -57.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FRZ A 1001 DBREF 1TVO A 1 360 UNP P28482 MK01_HUMAN 1 360 SEQADV 1TVO GLY A 361 UNP P28482 CLONING ARTIFACT SEQADV 1TVO ASP A 362 UNP P28482 CLONING ARTIFACT SEQADV 1TVO LEU A 363 UNP P28482 CLONING ARTIFACT SEQADV 1TVO GLY A 364 UNP P28482 CLONING ARTIFACT SEQADV 1TVO SER A 365 UNP P28482 CLONING ARTIFACT SEQADV 1TVO ASP A 366 UNP P28482 CLONING ARTIFACT SEQADV 1TVO GLU A 367 UNP P28482 CLONING ARTIFACT SEQADV 1TVO LEU A 368 UNP P28482 CLONING ARTIFACT SEQRES 1 A 368 MET ALA ALA ALA ALA ALA ALA GLY ALA GLY PRO GLU MET SEQRES 2 A 368 VAL ARG GLY GLN VAL PHE ASP VAL GLY PRO ARG TYR THR SEQRES 3 A 368 ASN LEU SER TYR ILE GLY GLU GLY ALA TYR GLY MET VAL SEQRES 4 A 368 CYS SER ALA TYR ASP ASN VAL ASN LYS VAL ARG VAL ALA SEQRES 5 A 368 ILE LYS LYS ILE SER PRO PHE GLU HIS GLN THR TYR CYS SEQRES 6 A 368 GLN ARG THR LEU ARG GLU ILE LYS ILE LEU LEU ARG PHE SEQRES 7 A 368 ARG HIS GLU ASN ILE ILE GLY ILE ASN ASP ILE ILE ARG SEQRES 8 A 368 ALA PRO THR ILE GLU GLN MET LYS ASP VAL TYR ILE VAL SEQRES 9 A 368 GLN ASP LEU MET GLU THR ASP LEU TYR LYS LEU LEU LYS SEQRES 10 A 368 THR GLN HIS LEU SER ASN ASP HIS ILE CYS TYR PHE LEU SEQRES 11 A 368 TYR GLN ILE LEU ARG GLY LEU LYS TYR ILE HIS SER ALA SEQRES 12 A 368 ASN VAL LEU HIS ARG ASP LEU LYS PRO SER ASN LEU LEU SEQRES 13 A 368 LEU ASN THR THR CYS ASP LEU LYS ILE CYS ASP PHE GLY SEQRES 14 A 368 LEU ALA ARG VAL ALA ASP PRO ASP HIS ASP HIS THR GLY SEQRES 15 A 368 PHE LEU THR GLU TYR VAL ALA THR ARG TRP TYR ARG ALA SEQRES 16 A 368 PRO GLU ILE MET LEU ASN SER LYS GLY TYR THR LYS SER SEQRES 17 A 368 ILE ASP ILE TRP SER VAL GLY CYS ILE LEU ALA GLU MET SEQRES 18 A 368 LEU SER ASN ARG PRO ILE PHE PRO GLY LYS HIS TYR LEU SEQRES 19 A 368 ASP GLN LEU ASN HIS ILE LEU GLY ILE LEU GLY SER PRO SEQRES 20 A 368 SER GLN GLU ASP LEU ASN CYS ILE ILE ASN LEU LYS ALA SEQRES 21 A 368 ARG ASN TYR LEU LEU SER LEU PRO HIS LYS ASN LYS VAL SEQRES 22 A 368 PRO TRP ASN ARG LEU PHE PRO ASN ALA ASP SER LYS ALA SEQRES 23 A 368 LEU ASP LEU LEU ASP LYS MET LEU THR PHE ASN PRO HIS SEQRES 24 A 368 LYS ARG ILE GLU VAL GLU GLN ALA LEU ALA HIS PRO TYR SEQRES 25 A 368 LEU GLU GLN TYR TYR ASP PRO SER ASP GLU PRO ILE ALA SEQRES 26 A 368 GLU ALA PRO PHE LYS PHE ASP MET GLU LEU ASP ASP LEU SEQRES 27 A 368 PRO LYS GLU LYS LEU LYS GLU LEU ILE PHE GLU GLU THR SEQRES 28 A 368 ALA ARG PHE GLN PRO GLY TYR ARG SER GLY ASP LEU GLY SEQRES 29 A 368 SER ASP GLU LEU HET FRZ A1001 25 HETNAM FRZ 5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3, HETNAM 2 FRZ 4-C]PYRIDAZIN-3-AMINE HETSYN FRZ FR180204 FORMUL 2 FRZ C18 H13 N7 FORMUL 3 HOH *148(H2 O) HELIX 1 1 HIS A 61 PHE A 78 1 18 HELIX 2 2 LEU A 112 LYS A 117 1 6 HELIX 3 3 SER A 122 ALA A 143 1 22 HELIX 4 4 LYS A 151 SER A 153 5 3 HELIX 5 5 ASP A 175 ASP A 179 5 5 HELIX 6 6 THR A 190 ARG A 194 5 5 HELIX 7 7 ALA A 195 ASN A 201 1 7 HELIX 8 8 LYS A 207 ASN A 224 1 18 HELIX 9 9 LEU A 234 GLY A 245 1 12 HELIX 10 10 ASN A 257 SER A 266 1 10 HELIX 11 11 PRO A 274 PHE A 279 1 6 HELIX 12 12 ASP A 283 LEU A 294 1 12 HELIX 13 13 GLU A 303 ALA A 309 1 7 HELIX 14 14 HIS A 310 GLU A 314 5 5 HELIX 15 15 ASP A 318 GLU A 322 5 5 HELIX 16 16 PRO A 339 THR A 351 1 13 HELIX 17 17 ALA A 352 GLN A 355 5 4 SHEET 1 A 5 TYR A 25 GLU A 33 0 SHEET 2 A 5 MET A 38 ASP A 44 -1 O SER A 41 N SER A 29 SHEET 3 A 5 VAL A 49 ILE A 56 -1 O VAL A 51 N ALA A 42 SHEET 4 A 5 VAL A 101 ASP A 106 -1 O VAL A 101 N ILE A 56 SHEET 5 A 5 ASP A 88 ILE A 90 -1 N ASP A 88 O VAL A 104 SHEET 1 B 3 THR A 110 ASP A 111 0 SHEET 2 B 3 LEU A 155 LEU A 157 -1 O LEU A 157 N THR A 110 SHEET 3 B 3 LEU A 163 ILE A 165 -1 O LYS A 164 N LEU A 156 SHEET 1 C 2 VAL A 145 LEU A 146 0 SHEET 2 C 2 ARG A 172 VAL A 173 -1 O ARG A 172 N LEU A 146 CISPEP 1 GLY A 22 PRO A 23 0 -0.42 SITE 1 AC1 10 ALA A 52 LYS A 54 ILE A 103 GLN A 105 SITE 2 AC1 10 ASP A 106 MET A 108 SER A 153 ASN A 154 SITE 3 AC1 10 CYS A 166 ASP A 167 CRYST1 48.860 69.990 63.300 90.00 116.50 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020467 0.000000 0.010204 0.00000 SCALE2 0.000000 0.014288 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017652 0.00000